Same-day Topamax appointment in Pennsylvania

If you’re struggling with Binge Eating Disorder (BED) and wondering whether you can access treatment through telehealth, the short answer is yes—and it’s easier than you might think. As of 2026, telehealth has become a mainstream, legally sound way to receive medication for BED in all 50 states, particularly for non-controlled medications like Topamax (topiramate) and Wellbutrin (bupropion).

This comprehensive guide will walk you through everything you need to know about getting BED treatment via telehealth: the medications available, state-by-state regulations, who can prescribe them, and what to expect during your virtual appointments.

Understanding Binge Eating Disorder and Treatment Options

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of people who experience recurrent episodes of eating large amounts of food while feeling out of control. According to DSM-5 criteria, BED is diagnosed when someone experiences binge eating episodes at least once a week for three months, along with marked distress about the behavior.

While therapy remains a cornerstone of BED treatment, medication can play an important supporting role. The challenge has always been access—many people live far from specialists, face long wait times, or struggle with the stigma of seeking in-person care for an eating disorder. Telehealth has changed that landscape dramatically.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Legal Landscape: Telehealth Prescribing in 2026

Federal Rules Are Clear and Favorable

Here’s the critical distinction that many patients don’t understand: medications for BED like Topamax and Wellbutrin are not controlled substances. This means they’re not subject to the strict Ryan Haight Act regulations that govern telehealth prescribing of controlled medications like ADHD stimulants or opioids.

For non-controlled medications, there has never been a federal requirement for an in-person visit before prescribing via telehealth. The DEA’s recent extensions and rule-making around telehealth prescribing (extended through December 31, 2026) primarily address controlled substances—the medications we’re discussing fall outside these restrictions entirely.

This is excellent news for patients seeking BED treatment. You can legally receive a prescription for topiramate or bupropion after a telehealth evaluation in every state, as long as your provider is licensed in your state and follows standard medical care protocols.

State-by-State Variations

While federal law is permissive, individual states have their own telehealth regulations. The good news? Most states have made permanent the pandemic-era flexibilities that expanded telehealth access. Here’s what you need to know about key states:

States With No In-Person Requirements

California, New York, Texas, Florida, Delaware, Michigan, Wisconsin, and South Carolina have no mandatory in-person visit requirements for non-controlled medication prescriptions via telehealth. In California, lawmakers even clarified in 2025 that a ‘good faith exam’ can include asynchronous telehealth (like detailed online questionnaires), as long as it meets the standard of care.

New York went a step further in May 2025 by implementing rules requiring in-person exams for controlled substance prescriptions, but explicitly exempted non-controlled medications like those used for BED. This demonstrates the state’s commitment to maintaining broad telehealth access for appropriate medications.

States With Periodic Follow-Up Requirements

A handful of states—Alabama, Georgia, and New Hampshire—require periodic in-person follow-ups for ongoing telehealth care, but these can often be satisfied in flexible ways:

• Alabama requires an in-person visit within 12 months if you have more than four telehealth visits for the same condition. However, this can be satisfied by seeing any collaborating provider in person, not necessarily your telehealth prescriber.

• Georgia asks that providers attempt an annual in-person examination for continued telemedicine care, but the initial evaluation can be done entirely via telehealth if it’s equivalent to an in-person exam.

• New Hampshire recently modernized its telehealth laws in August 2025, requiring an in-person exam within 12 months for controlled substance prescriptions but maintaining flexibility for non-controlled medications.

Even in these states, you can start treatment entirely online and work with your provider on scheduling any required follow-ups.

Medications Available via Telehealth for BED

Topamax (Topiramate)

Topiramate is an FDA-approved medication for seizures and migraine prevention, but it’s frequently prescribed off-label for Binge Eating Disorder. Clinical research suggests it can help reduce binge frequency and support weight management in some patients.

Key Information:

• Schedule Status: Non-controlled (no DEA restrictions)
• Typical Supply: Up to 90 days with refills
• Starting Approach: Usually started at a low dose and gradually increased to minimize side effects
• Monitoring Needs: Regular weight checks, metabolic monitoring, and cognitive function assessments

Important Precautions:Topiramate carries significant pregnancy risks, including an increased chance of cleft palate and other birth defects when taken during the first trimester. If you’re of childbearing potential, your telehealth provider will discuss effective contraception before starting this medication. The drug should be tapered gradually if discontinued to avoid seizure risk.

Wellbutrin (Bupropion)

Bupropion is FDA-approved for depression and smoking cessation, with evidence supporting its off-label use for reducing binge eating episodes. It works differently than typical antidepressants and can be particularly helpful for patients who also struggle with depression or low energy.

Key Information:

• Schedule Status: Non-controlled
• Typical Supply: Up to 90 days with refills
• Black Box Warning: Like all antidepressants, bupropion carries a warning about increased suicidal thoughts in young adults under 25, requiring close monitoring

Critical Contraindications:Bupropion should not be used if you have a history of bulimia or anorexia nervosa due to an elevated seizure risk. It’s also contraindicated for anyone with a seizure disorder or who is abruptly discontinuing alcohol or benzodiazepines. Your telehealth provider will carefully screen for these conditions before prescribing.

Monitoring Requirements:Patients on bupropion should avoid alcohol (which increases seizure risk), and providers typically monitor blood pressure, especially if you’re taking other medications or have cardiovascular concerns.

Who Can Prescribe BED Medications via Telehealth?

Medical Doctors and Doctors of Osteopathy

MDs and DOs can prescribe Topamax and Wellbutrin in all states via telehealth, provided they’re licensed in the state where you’re located at the time of the appointment.

Nurse Practitioners and Physician Assistants

The landscape for NP and PA prescribing has evolved dramatically. As of 2026, about 34 states plus Washington, D.C. grant Nurse Practitioners full practice authority, meaning they can evaluate, diagnose, and prescribe independently without physician oversight.

States with NP Full Practice Authority include:

• Recent additions (2023-2025): Louisiana, Kansas, Wisconsin, Michigan
• Long-standing: California, New York, New Hampshire, Delaware, and many others

In these states, an NP working with a telehealth platform can provide complete BED care without requiring a collaborating physician.

States Requiring Collaboration:

In states like Florida, Texas, Georgia, and Alabama, NPs and PAs must work under a collaborative agreement or supervision by a physician. This doesn’t typically affect your access to care—it’s a behind-the-scenes regulatory requirement. Your prescription might list both the NP’s name and the collaborating physician’s name.

The good news? For non-controlled medications like those used for BED, even in collaborative practice states, NPs and PAs can prescribe these treatments. The restrictions primarily apply to controlled substances.

Recent Developments

Wisconsin and Michigan both passed legislation in 2023-2025 expanding NP independence, joining the growing number of states recognizing advanced practice nurses’ ability to provide autonomous care. This trend continues to improve access to mental health and eating disorder treatment via telehealth.

The Telehealth Evaluation Process: What to Expect

Initial Assessment

A legitimate telehealth evaluation for BED should be thorough—typically 30 minutes or longer for an initial consultation. Your provider will ask detailed questions about:

• Eating behaviors: Frequency of binge episodes, typical amounts consumed, feelings of loss of control
• Duration: How long you’ve experienced these symptoms (DSM-5 requires at least three months)
• Associated features: Eating when not hungry, eating alone due to embarrassment, feeling disgusted or guilty afterward
• Other symptoms: Whether you engage in compensatory behaviors like purging (which would suggest a different diagnosis)
• Mental health history: Depression, anxiety, trauma, or other psychiatric conditions
• Medical history: Current medications, allergies, previous treatments, medical conditions
• Substance use: Alcohol, tobacco, or other substances that might interact with medications

Some providers use standardized questionnaires like the Eating Disorder Examination Questionnaire (EDE-Q) or Binge Eating Scale (BES) to assess severity and track progress.

Safety Screening

Before prescribing medication, your provider will screen for contraindications:

• History of seizure disorders
• Previous eating disorders involving purging (for bupropion)
• Pregnancy or breastfeeding status
• Current medications that might interact
• Liver or kidney problems
• Cardiovascular conditions

This screening process is not meant to exclude you from care but to ensure any medication prescribed is safe for your specific situation.

Identity and Location Verification

Don’t be surprised when your telehealth provider verifies your identity and location at the start of your visit. Many states require this to ensure the provider is licensed where you’re receiving care and to prevent fraud. This is standard practice and a sign of a legitimate, compliant service.

Treatment Planning

A quality telehealth provider won’t just hand you a prescription and send you on your way. They should discuss:

• Medication options: Why a particular medication is recommended, expected benefits, and potential side effects
• Off-label use: Clear explanation that these medications are used off-label for BED, what the evidence shows, and what this means for you
• Therapy recommendations: Medication works best combined with therapy—expect recommendations for cognitive-behavioral therapy, dialectical behavior therapy, or nutrition counseling
• Lifestyle modifications: Discussion of eating patterns, stress management, and other supportive strategies
• Monitoring plan: How often you’ll follow up, what symptoms to watch for, and how to reach the provider between appointments

Prescription and Pharmacy Coordination

Your telehealth provider will send your prescription electronically to a pharmacy of your choice. You should be able to pick up your medication from any regular pharmacy or use a legitimate mail-order pharmacy.

Red flag: If a telehealth service wants to ship you medication directly without going through a licensed pharmacy, that’s not standard practice and should raise concerns.

Ongoing Care and Follow-Up

Follow-Up Schedule

Expect regular check-ins, especially when starting a new medication:

• 2-week follow-up: Initial check on tolerability and side effects
• Monthly visits: For the first few months to assess response and adjust dosing
• Ongoing care: Every 1-3 months once stable, depending on your state’s requirements and clinical needs

Some states mandate periodic follow-ups for telehealth patients. For example, Alabama and Georgia require annual in-person visits for ongoing telehealth care, though this can often be satisfied by seeing any local provider, not necessarily your telehealth prescriber.

Refill Management

Because these are non-controlled medications, your provider can authorize refills for an extended period—often 6-12 months depending on state regulations. However, you’ll still need regular check-in appointments to ensure the medication is working and remains appropriate.

Adjusting Treatment

BED treatment often requires adjustments. Your provider might:

• Increase or decrease dosages based on response and side effects
• Add or change medications if the first choice isn’t effective
• Recommend additional therapies or specialists
• Taper medications if you’re doing well and ready to try managing without them

Who Should NOT Pursue Telehealth BED Treatment?

Telehealth is powerful, but it’s not appropriate for everyone. You may need in-person care if you have:

Active Medical Instability

• Severe obesity with urgent complications
• Uncontrolled diabetes, heart disease, or other conditions requiring hands-on monitoring
• Frequent syncopal episodes or neurological symptoms needing physical examination

Contraindications to Available Medications

• Active bulimia or anorexia nervosa (bupropion contraindicated)
• Uncontrolled epilepsy or seizure disorder
• Pregnancy or planning pregnancy (especially for topiramate)
• Multiple complex medical conditions requiring careful medication management

Need for Controlled Substances

The only FDA-approved medication for BED is Vyvanse (lisdexamfetamine), a controlled stimulant. Due to stricter DEA regulations on controlled substance prescribing via telehealth, most legitimate telehealth services don’t prescribe stimulants for BED. If your treatment requires controlled medications, you’ll likely need an in-person evaluation.

Complex or Severe Eating Disorder

If you need intensive treatment, such as:

• Partial hospitalization or intensive outpatient programs
• Nutritional rehabilitation with medical monitoring
• Treatment for multiple co-occurring eating disorders
• Management of severe medical complications from binge eating

In these cases, telehealth can complement but not replace comprehensive in-person care.

Understanding Off-Label Prescribing

Both topiramate and bupropion are prescribed off-label for BED. This is completely legal and very common in medicine—especially in psychiatry and eating disorder treatment where few medications have specific FDA approval for these conditions.

What ‘off-label’ means:

• The FDA has approved the medication as safe and effective for other conditions
• Clinical research and medical guidelines support its use for BED
• Your doctor uses their medical judgment and expertise to prescribe it for your condition
• Insurance may or may not cover off-label uses (though many do)

A reputable telehealth provider will:

• Clearly explain that they’re prescribing off-label
• Review the evidence supporting this use
• Discuss why this medication is appropriate for you specifically
• Obtain your informed consent
• Document all of this in your medical record

Ensuring Quality and Safety in Telehealth Care

The rapid expansion of telehealth has unfortunately included some bad actors. High-profile cases—like the 2024 indictment of executives from an ADHD telehealth company for unsafe stimulant prescribing—have prompted increased scrutiny and better regulations.

Signs of a Legitimate Telehealth Service

Quality providers will:

• Conduct thorough evaluations (30+ minutes for initial visits)
• Ask detailed questions about your medical and psychiatric history
• Screen for contraindications and safety concerns
• Verify your identity and location
• Provide clear consent forms explaining telehealth limitations
• Discuss multiple treatment options, including therapy
• Schedule regular follow-up appointments
• Send prescriptions to licensed pharmacies
• Maintain secure electronic health records
• Have clear policies about privacy and data security

Klarity Health exemplifies these best practices, offering transparent pricing, accepting both insurance and cash pay, and ensuring provider availability for regular follow-ups—all critical elements of safe, effective telehealth care.

Red Flags to Avoid

Be cautious of services that:

• Promise prescriptions before conducting an evaluation
• Complete evaluations in just a few minutes
• Don’t discuss therapy or other treatment options
• Start you on high doses immediately
• Want to ship medication directly rather than using a pharmacy
• Have no clear process for follow-up care
• Charge exorbitant fees without price transparency
• Don’t verify your location or medical history

Prescription Monitoring Programs (PMPs)

Many patients wonder whether their telehealth provider will check the state Prescription Drug Monitoring Program before prescribing.

For non-controlled medications like topiramate and bupropion, most states don’t legally require PMP checks. These databases primarily track controlled substances to prevent ‘doctor shopping’ and identify potential substance misuse.

That said, responsible providers may still review your medication history as good clinical practice—ensuring you’re not on overlapping medications or something that could interact dangerously. This is a safety measure, not a mark against you.

Insurance and Cost Considerations

Insurance Coverage

Most major insurance plans now cover telehealth visits at parity with in-person visits, thanks to regulations implemented during and after the pandemic. Your telehealth evaluation and follow-ups should be covered similarly to office visits.

Medication coverage varies:

• Many plans cover topiramate and bupropion for approved uses (seizures, depression, etc.)
• Off-label coverage for BED varies by plan—some cover it readily, others require prior authorization
• Your provider can submit documentation supporting medical necessity

Cash Pay Options

If you’re uninsured or prefer not to use insurance, many telehealth platforms offer transparent cash pricing. Services like Klarity Health provide clear upfront pricing for both visits and medication management, eliminating surprise bills.

Cash pay can range from $99-$299 for initial evaluations, with follow-ups typically $75-$150. Medications themselves are often affordable—generic topiramate and bupropion can cost $10-$50 per month at most pharmacies.

State-Specific Quick Reference

No In-Person Requirements

California, New York, Delaware, Florida, Texas, Michigan, Wisconsin, South Carolina

• Initial evaluation can be done entirely via telehealth
• No mandatory in-person follow-ups for non-controlled medications
• Standard care protocols apply

Periodic In-Person Follow-Up States

Alabama

• In-person visit required within 12 months if more than 4 telehealth visits for same condition
• Can be satisfied by local collaborating provider

Georgia

• Annual in-person visit attempt required for ongoing telehealth care
• Initial visit can be fully remote

New Hampshire

• 12-month in-person follow-up for controlled substances only
• Non-controlled medications have no special requirements

Recent Regulatory Updates (2025-2026)

Federal Developments

The DEA extended its COVID-era telehealth prescribing flexibilities through December 31, 2026, maintaining expanded access for controlled substance prescribing while permanent rules are finalized. This doesn’t directly affect non-controlled BED medications, but it signals continued federal support for telehealth.

State Legislative Activity

New Hampshire (August 2025): Passed SB 252 explicitly allowing telehealth prescribing of Schedule II-IV controlled substances with annual in-person follow-up, modernizing the state’s telehealth framework.

New York (May 2025): Implemented final rules requiring in-person exams for controlled substance prescriptions (with limited exceptions) but explicitly exempted non-controlled medications.

Wisconsin (August 2025): Passed the APRN Modernization Act granting nurse practitioners full practice authority, expanding access to prescribers.

Michigan (2023-2025): Implemented Public Act 47 of 2023, giving NPs full practice authority by 2025.

California (2025): AB 1503 redefined ‘good faith exam’ to include asynchronous telehealth, further expanding prescribing flexibility.

States to Watch

Alabama and South Carolina have both seen legislation introduced to grant NPs full practice authority, though neither has passed as of early 2026. If enacted, these changes would further expand prescriber availability in telehealth.

The Bottom Line: Your Path to Telehealth BED Treatment

Getting help for Binge Eating Disorder through telehealth is not only legal and safe—it’s often the most accessible option for many patients. Here’s how to get started:

Step 1: Choose a Reputable Provider

Research telehealth platforms that specialize in mental health and eating disorder treatment. Look for services with licensed providers in your state, transparent pricing, and clear treatment protocols. Klarity Health connects patients with experienced providers who understand BED and accept both insurance and cash pay.

Step 2: Schedule an Evaluation

Book an initial consultation. Be prepared to spend 30-45 minutes discussing your eating behaviors, medical history, and treatment goals.

Step 3: Be Honest and Thorough

Provide complete information about your symptoms, medical history, and any medications you’re taking. The more your provider knows, the better they can help.

Step 4: Discuss All Options

A quality provider will discuss medication alongside therapy, nutrition counseling, and lifestyle approaches. BED treatment works best with multiple strategies.

Step 5: Commit to Follow-Up

Regular check-ins are essential for monitoring medication effectiveness and safety. Schedule follow-ups as recommended and communicate any concerns between appointments.

Step 6: Combine with Therapy

Medication can reduce binge frequency and support recovery, but therapy addresses the underlying psychological factors driving BED. Consider cognitive-behavioral therapy (CBT) or dialectical behavior therapy (DBT) alongside medication.

Looking Forward

The telehealth landscape for eating disorder treatment continues to evolve in positive directions. With most states maintaining pandemic-era flexibilities, expanded NP practice authority in many regions, and continued federal support for telemedicine, access to BED treatment has never been better.

Whether you’re in a rural area with no local eating disorder specialists, struggling with mobility issues, or simply prefer the privacy and convenience of telehealth, you can receive quality, evidence-based care for Binge Eating Disorder.

The key is choosing providers who prioritize thoroughness over speed, safety over convenience, and comprehensive care over quick prescriptions. When done right, telehealth brings specialty eating disorder treatment to anyone with an internet connection—breaking down the barriers that have kept too many people from getting the help they need.

If you’re ready to take the first step toward managing your BED, explore telehealth options with established platforms that offer the expertise, availability, and support structure you deserve. Recovery is possible, and it’s now more accessible than ever.

Research Currency Statement

Verified as of: January 4, 2026

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

• Sources Newer Than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

• Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Key Citations

1. HHS Press Release (January 2, 2026): DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026. Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Healthcare Law Blog (August 2025): Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions. Available at: https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy (November-December 2025): State Telehealth Laws and Reimbursement Policies Database. Available at: https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide Blog (2025): State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025). Available at: https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. National Law Review (May-November 2025): Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions. Available at: https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12